Literature DB >> 19894271

The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals.

Tsutomu Arakawa1, Daisuke Ejima, Tiansheng Li, John S Philo.   

Abstract

Size exclusion chromatography (SEC) is the most widely used method for aggregation analysis of pharmaceutical proteins. However SEC analysis has a number of limitations, and one of the most important ones is protein adsorption to the resin. This problem is particularly severe when using new columns, and often column preconditioning protocols are required. This review focuses on the role that addition of various cosolvents to the mobile phase plays in suppressing that protein adsorption. Cosolvents such as salt, amino acids, and organic solvents are often used for this purpose. Because the protein interaction with the resin surface is highly heterogeneous, different cosolvents affect the protein adsorption differently. We will summarize the various effects of cosolvents on protein adsorption and retention and describe the mechanism of the cosolvent effects. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19894271     DOI: 10.1002/jps.21974

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  Rapid quantitative analysis of monoclonal antibody heavy and light chain charge heterogeneity.

Authors:  Ram P Vanam; Michael A Schneider; Michael S Marlow
Journal:  MAbs       Date:  2015-08-25       Impact factor: 5.857

2.  Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.

Authors:  Ujjwal Rathore; Piyali Saha; Sannula Kesavardhana; Aditya Arun Kumar; Rohini Datta; Sivasankar Devanarayanan; Raksha Das; John R Mascola; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

3.  Aggregation mechanism of an IgG2 and two IgG1 monoclonal antibodies at low pH: from oligomers to larger aggregates.

Authors:  Paolo Arosio; Simonetta Rima; Massimo Morbidelli
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

4.  Analyzing insulin samples by size-exclusion chromatography: a column degradation study.

Authors:  Brandon M Teska; Amit Kumar; John F Carpenter; Michael F Wempe
Journal:  J Pharm Sci       Date:  2015-01-07       Impact factor: 3.534

5.  Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

Authors:  Indu Javeri; Kaliappanadar Nellaiappan; Charles McNemar; Kirill Yakovlevsky; Amina Soukrati; Phanindra Velisetty; Bijay Misra
Journal:  Pharm Res       Date:  2018-06-26       Impact factor: 4.200

Review 6.  Sedimentation velocity analytical ultracentrifugation for characterization of therapeutic antibodies.

Authors:  Susumu Uchiyama; Masanori Noda; Elena Krayukhina
Journal:  Biophys Rev       Date:  2017-12-14

7.  Hydrodynamic size-based separation and characterization of protein aggregates from total cell lysates.

Authors:  Maya Tanase; Valerio Zolla; Cristina C Clement; Francesco Borghi; Aleksandra M Urbanska; Jose Antonio Rodriguez-Navarro; Barbara Roda; Andrea Zattoni; Pierluigi Reschiglian; Ana Maria Cuervo; Laura Santambrogio
Journal:  Nat Protoc       Date:  2014-12-18       Impact factor: 13.491

Review 8.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.

Authors:  Steven A Berkowitz; John R Engen; Jeffrey R Mazzeo; Graham B Jones
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

9.  Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics.

Authors:  Sahithi Ravuluri; Rohit Bansal; Nidhi Chhabra; Anurag S Rathore
Journal:  Pharm Res       Date:  2018-05-14       Impact factor: 4.200

10.  Overcoming the Multiple-Monomeric-Peak Profile of Broadly Neutralizing HIV-1 Antibody 10E8 with a Unique Size-Exclusion-Chromatography Method.

Authors:  Yile Li; Xiangchun E Wang; Michael F Bender; Rong Yang; Taryn J Cozine; Kandace M Atallah; Frank Arnold; Jonathan W Cooper; Q Paula Lei
Journal:  Anal Chem       Date:  2018-10-22       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.